Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 2/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9262832 | 0.88 | TBXAS1 (0.54) | TBXAS1KMT2AMAPTALDH1A1TSHR | |
| SCHEMBL9264092 | 0.82 | TBXAS1 (0.70) | TBXAS1KMT2ATP53MAPK1MAPT | |
| SCHEMBL9266704 | 0.82 | TBXAS1 (0.70) | TBXAS1KMT2ATP53MAPK1MAPT | |
| SCHEMBL11272924 | 0.80 | MAPT (0.62) | TBXAS1KMT2AMAPK1MAPTALDH1A1 | |
| SCHEMBL10700909 | 0.78 | KMT2A (0.54) | KMT2ATP53MAPK1MAPTALDH1A1 | |
| SCHEMBL9266468 | 0.77 | MEN1 (0.72) | KMT2ATP53MAPK1MAPTALDH1A1 | |
| SCHEMBL9260326 | 0.77 | MEN1 (0.72) | KMT2ATP53MAPK1MAPTALDH1A1 | |
| SCHEMBL9267414 | 0.77 | MEN1 (0.72) | KMT2ATP53MAPK1MAPTALDH1A1 | |
| SCHEMBL9260580 | 0.77 | MEN1 (0.72) | KMT2ATP53MAPK1MAPTALDH1A1 | |
| SCHEMBL9266828 | 0.77 | ADRA2C (0.51) | TBXAS1KMT2ATP53MAPK1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0274867-A2 | Pharmaceutically active compounds | SCHERING CORPORATION (US) | 1988-07-20 | — | — | EP | claimed |
| US-5459144-A | Enterovirus and rhinovirus antiviral, antiinflammatory and antagonist of platelet activating factor | SCHERING CORPORATION (US) | 1995-10-17 | — | — | US | disclosed |
| US-5272167-A | Pharmaceutically active compounds | SCHERING CORPORATION (US) | 1993-12-21 | — | — | US | disclosed |
| EP-0560407-A1 | Pharmaceutically active compounds | SCHERING CORPORATION (US) | 1993-09-15 | — | — | EP | disclosed |
| WO-1991000858-A1 | PHARMACEUTICALLY ACTIVE COMPOUNDS | SCHERING CORPORATION (US) | 1991-01-24 | — | — | WO | disclosed |
| EP-0407217-A1 | Pharmaceutically active compounds | SCHERING CORPORATION (US) | 1991-01-09 | — | — | EP | disclosed |
| US-4851423-A | Pharmaceutically active compounds | SCHERING CORPORATION (US) | 1989-07-25 | — | — | US | disclosed |
| EP-0274867-A2 | Pharmaceutically active compounds | SCHERING CORPORATION (US) | 1988-07-20 | — | — | EP | disclosed |